What Is a Technical File and Is It Required for SFDA Registration?

A technical file is a comprehensive documentation package required for SFDA registration that contains detailed information about your medical device’s design, manufacturing, and safety. Yes, a technical file is mandatory for all medical device registrations with the Saudi Food and Drug Authority (SFDA) to obtain Medical Devices Marketing Authorization (MDMA).

The SFDA revised its regulatory requirements in 2021 to align more closely with EU Medical Devices Regulation standards, making technical file submissions more rigorous and detailed. Furthermore, manufacturers without a legal entity in Saudi Arabia must work with a Saudi Arabia Authorized Representative to handle the preparation and submission of all required documentation, including the technical file.

Understanding the specific requirements and timing for technical file submission ensures smoother SFDA registration and helps avoid costly delays in bringing your medical devices to the Saudi market.

What documents are included in a technical file for SFDA?

A technical file for SFDA registration must include comprehensive device documentation, risk management files, CE certificates when applicable, labeling materials, Instructions for Use, a Certificate of Free Sale, and the Manufacturer’s Declaration of Conformity. Additionally, manufacturers must provide company registration documents and detailed technical specifications.

The risk management documentation represents a critical component of the technical file. Manufacturers must provide comprehensive Risk Management Files that comply with ISO 14971:2019 standards, including risk management reports and post-market risk updates. These documents demonstrate systematic identification of hazards, risk analysis, and implementation of appropriate risk controls throughout the device lifecycle.

Labeling and instructional materials form another essential element of the technical file. The SFDA requires all labeling materials to be reviewed for conformity with Saudi regulations, and the Instructions for Use must be comprehensive and clearly written. Importantly, the Authorized Representative’s name, address, and contact details must appear on device labeling, packaging, and Instructions for Use in accordance with SFDA regulations.

When applicable, CE certification documentation strengthens the technical file submission. The SFDA recognizes CE marking as evidence of conformity with international standards, though manufacturers must still demonstrate compliance with Saudi-specific requirements. The Authorized Representative retains copies of technical documentation and CE certification, providing them to the SFDA for review only upon request.

How does SFDA’s technical file differ from EU MDR requirements?

SFDA technical file requirements closely align with EU MDR standards following the 2021 regulatory revision, but Saudi Arabia maintains specific additional requirements for local market compliance. The SFDA has adopted similar classification rules and technical documentation standards while adding country-specific elements for device registration and post-market surveillance.

One significant difference lies in the Authorized Representative requirements. While EU MDR requires European Authorized Representatives for non-EU manufacturers, the SFDA mandates Saudi Arabia Authorized Representatives who must maintain SFDA-issued licenses that require annual renewal. This representative must be an individual or company located specifically within Saudi Arabia and must possess expertise in SFDA device registration and post-market compliance requirements.

The submission process also differs in terms of local regulatory oversight. The SFDA conducts meticulous reviews of MDMA applications with particular attention to Saudi-specific compliance requirements. Manufacturers must demonstrate adherence to local labeling requirements, and the technical file must include documentation that addresses Saudi Arabia’s unique regulatory landscape and post-market surveillance expectations.

Additionally, the SFDA requires specific company registration documents that may not be necessary for EU MDR compliance. These documents establish the manufacturer’s legal standing and demonstrate compliance with Saudi business registration requirements, creating an additional layer of documentation beyond standard EU technical file requirements.

When must you submit your technical file during SFDA registration?

The technical file must be submitted as part of the initial Medical Devices Marketing Authorization application to the SFDA, typically prepared and submitted by the Saudi Arabia Authorized Representative on behalf of the manufacturer. The submission occurs during the formal registration process before any device can be legally marketed in Saudi Arabia.

The Authorized Representative plays a crucial role in timing and managing the submission process. This representative handles the preparation and submission of all required documentation for Medical Devices Marketing Authorization and company registration, ensuring that materials are properly formatted and complete before submission. The AR also manages all interactions with the SFDA throughout the review process, responding efficiently to requests for additional information.

Manufacturers should begin preparing their technical file well in advance of their intended market entry date. The SFDA review process requires time for thorough evaluation of submitted materials, and any deficiencies or requests for additional information can extend the timeline. Building buffer time into the submission schedule helps accommodate potential delays and ensures smoother market entry.

Post-submission, the technical file becomes part of ongoing compliance obligations. The Authorized Representative must maintain current versions of all technical documentation and ensure that any device modifications or updates are properly reported to the SFDA to maintain post-market compliance throughout the product lifecycle.

What happens if your technical file is rejected by SFDA?

If the SFDA rejects your technical file, you will receive specific feedback detailing the deficiencies that must be addressed before resubmission. The rejection typically identifies missing documentation, inadequate risk management information, labeling non-compliance, or insufficient technical specifications that require correction.

The Authorized Representative serves as the primary point of contact for managing rejection responses and resubmission processes. This representative reviews the SFDA’s feedback, coordinates with the manufacturer to address identified deficiencies, and prepares the corrected documentation for resubmission. The AR’s expertise in SFDA requirements proves invaluable in interpreting regulatory feedback and implementing appropriate corrections.

Common rejection reasons include incomplete risk management documentation, inadequate labeling compliance, missing CE certification when applicable, or insufficient technical specifications. Manufacturers must work systematically through each identified deficiency, providing comprehensive documentation that fully addresses the SFDA’s concerns before attempting resubmission.

The resubmission process requires careful attention to detail and complete resolution of all identified issues. Partial corrections or inadequate responses to SFDA feedback can result in additional rejections, further delaying market entry. Working with an experienced Authorized Representative who understands SFDA requirements and common rejection patterns significantly improves the likelihood of successful resubmission and approval.

How MedEnvoy helps with SFDA technical file preparation

MedEnvoy provides comprehensive In-Country Representation services that streamline SFDA technical file preparation and submission for medical device manufacturers. As an ISO 13485-certified provider with extensive experience in Saudi Arabia regulatory requirements, MedEnvoy ensures technical files meet all SFDA standards while minimizing the risk of rejection.

• Expert preparation and review of all technical file components, including risk management documentation, labeling materials, and regulatory submission materials
• Direct liaison with SFDA throughout the review process, handling all communication and responding to requests for additional information
• Ongoing post-market compliance support, including device modification reporting and adverse event management
• Annual license renewal management and maintenance of current technical documentation

With thousands of successful regulatory projects completed and over 10,000 medical devices represented, MedEnvoy combines proven expertise with cutting-edge technologies to deliver efficient, high-quality solutions for SFDA registration. Contact MedEnvoy today to discuss how their specialized Saudi Arabia Authorized Representative services can accelerate your market entry while ensuring full regulatory compliance.

Related Articles

• What Is CE Marking and Do US Medical Device Companies Need It?
• What Are the Costs Involved in US Medical Device Export?
• How Do I Prepare My Medical Device for European Approval?
• Are European Medical Device Requirements Different From the US?
• How Do I Sell Medical Devices in Italy?